URGENT PANDEMIC INFORMATION

In light of the pandemic situation events until September 2021 are cancelled. We will inform customers directly when the events are rescheduled.    
COVID CANCELLED: Project Management in Human Resources,   Boston MA, Jan 6-8, 2021
COVID CANCELLED: InterDrone, The International Drone Conference,   Cambridge MA, Jan 11-13, 2021
COVID CANCELLED: Supplier Management for Medical Device Manufacturers,   Cambridge MA, Feb 2-4, 2021
COVID CANCELLED: US Immigration Compliance Strategies,   Boston MA, Feb 15-18, 2021
COVID CANCELLED: Project Management Training,   Boston MA, Mar 3-5, 2021
COVID CANCELLED: Internal Audit, Fraud Risk Assessment Workshop,   Boston MA, Mar 22-25, 2021
COVID CANCELLED: Agile / Scrum Training,   Boston MA, Apr 12-14, 2021
COVID CANCELLED: Validation, Verification and Transfer of Analytical Methods,   Boston MA, Apr 19-21, 2021
COVID CANCELLED: Computer System Validation - Reduce Costs and Avoid 483s,   Boston MA, May 10-12, 2021
COVID CANCELLED: SharePoint Technology Conference,   Boston MA, May 26-28, 2021
COVID CANCELLED: Employment Laws Certificate Program,   Boston MA, Jun 7-9, 2021
Following events are tentatively planned but may be rescheduled, based on CDC guidelines or attendee registration interest .    
TENTATIVE: 21 CFR Part 11 Compliance,   Boston MA, Sep 22-24, 2021
TENTATIVE: Quality Control Laboratory Compliance,   Boston MA, Oct 6-8, 2021
TENTATIVE: Analytical Instrument Qualification and System Validation,   Boston MA, Nov 15-17, 2021
TENTATIVE: FDA's New Import Program for 2021,   Boston MA, Dec 7-9, 2021

Boston Professional Events List


3rd Genetic Vaccine Development for Infectious Diseases Summit


Date
Apr 04, 2023 - 08:00 AM - Apr 06, 05:30 PM
Organizer
Hanson Wade
Venue
The Colonnade Hotel
Location
120, Huntington Ave

Boston,
MA,
USA,
ZIP: 02116
Phone: +16174554188

Ticket Price: USD 2599.00 - USD 5846.00

The 3rd Genetic Vaccine Development for Infectious Disease Summit 2023 returns to Boston to unite world leaders in vaccine development. This year leading industry minds are gathering to overcome critical bottlenecks in genetic vaccine R&D and review pioneering platforms to expand the horizon toward treatments of untreated pathogens to provide better treatments to prevent and cure diseases for patients in need.

Curated for biopharma leaders looking to integrate novel vaccine development approaches into their R&D efforts through pre-clinical studies to clinical translation. This forum is shining a spotlight on applications toward future successes in DNA and viral vector vaccines.

Join 80+ leading vaccine developers from infectious diseases and virology for this one-of-a-kind event. Together we revolutionize the next era of vaccinology to prevent infectious diseases worldwide.

URLs:
Brochure: https://go.evvnt.com/1453838-0?pid=1052
Tickets: https://go.evvnt.com/1453838-2?pid=1052

Prices:
Drug Developer - Conference + Workshop Day: USD 4946.00,
Drug Developer - Conference Only: USD 2999.00,
Solution Provider - Conference + Workshop Day: USD 5846.00,
Solution Provider - Conference Only: USD 3599.00,
Academic - Conference + Workshop Day: USD 4246.00,
Academic - Conference Only: USD 2599.00

Speakers: Ami Patel, Caspar Wistar Fellow, The Wistar Institute, Christopher Cooper, Director - Viral Vaccines, Vaccine Design and Development Laboratory, International AIDS Vaccine Initiative (IAVI), Chunlin Xin, VP, CanSino Biologics Inc., Darina Spasova, Director - Pharmacology, Replicate Bioscience, Demin Zhu, Chief Executive Officer, Cureport, Inc, Gunnstein Norheim, Director Infectious Diseases, Nykode Therapeutics, Heinrich Haas, Vice President, RNA Formulation and Drug Delivery, BioNTech AG, Jakob Cramer, Head Of Clinical Development, CEPI, Jesse Erasmus, Director - Virology, HDT Bio, Joshua DiNapoli, Global Project Head, Sanofi, Judith Alamares-Sapuay, Biotherapeutics Manager, Sanofi Pasteur, Kay Hunsberger, Executive Director, Merck and Co, Mohamed ElSayed, Executive Vice President and Chief Technology Officer, RVAC Medicines, Nerea Zabaleta, Instructor, Beth Israel Deaconess Medical Center, Robert Van Den Berg, Independent Expert, Vaccine Technologies, Shan Lu, Professor, University of Massachusetts Medical School, Simon van Haren, Principal Investigator, Precision Vaccines Program, Boston Children's Hospital, Children's Hospital Boston, Stephen Shrewsbury, Chief Medical Officer, Impel Pharmaceuticals Inc., Sunetra Gupta, Professor, University of Oxford, Trevor Smith, Vice President, Inovio Pharmaceuticals

Event Categories
Keywords: conference , pharmaceutical




Comments








Events Calendar

SunMonTueWedThuFriSat
26 27 28 29 30 31 1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 1 2 3 4 5 6

Event Location

Newsletters

VIP Life Time Subscription to our Newsletters!
$399.99
$299.99